CLINICAL RESEARCH
P-selectin glycoprotein ligand-1 variable number of tandem repeats polymorphism in young myocardial infarction patients
 
More details
Hide details
 
Submission date: 2016-10-17
 
 
Final revision date: 2016-11-24
 
 
Acceptance date: 2016-11-24
 
 
Publication date: 2016-12-06
 
 
Arch Med Sci Civil Dis 2016;1(1):112-113
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: The prevalence of acute myocardial infarction (AMI) among young patients is increasing. Although the risk factors of AMI are well defined in the middle aged population, they are not clearly elucidated in young patients. Alternative risk factors such as genetic factors are being investigated. The P-selectin ligand gene, encoding P-selectin glycoprotein ligand-1 (PSGL-1), plays a role in atherosclerosis. In this study, we aimed to investigate whether there is an association between the PSGL-1 variable numbers of tandem repeats (VNTR) polymorphism and AMI in a young Turkish population.
Material and methods: We examined 119 young patients, less than 40 years old, presenting ST elevation AMI and undergoing percutaneous coronary intervention, and 53 sex and age matched controls with a normal coronary angiogram. Genomic DNAs were collected from whole blood samples by standard methods. The PSGL-1 was amplified by polymerase chain reaction.
Results: Ninety four (78.9%) showed AA, 15 (12.6%) showed AB, 4 (3.3%) showed BB, 4 (3.3%) showed AC and 2 (1.7%) showed BC genotype in the young AMI group, and 40 (75.4%) showed AA, 9 (16.9%) showed AB, 3 (5.6%) showed BB, 0 (0%) showed AC and 1 (1.8%) showed BC genotype in the control group. PSGL-1 VNTR genotype frequencies were similar between groups (p = 0.64). Smoking was significantly higher in the young AMI group (p = 0.025).
Conclusions: In this study, we found no significant difference between the PSGL-1 variable numbers of tandem repeats polymorphism and AMI in a young Turkish population. Further studies with additional polymorphisms are needed for further information about the genetic influences on premature myocardial infarction.
 
REFERENCES (15)
1.
Jamil G, Jamil M, AlKhazraji H, et al. Risk factor assessment of young patients with acute myocardial infarction. Am J Cardiovasc Dis 2013; 3: 170-4.
 
2.
Trzos E, Uznańska B, Rechciński T, et al. Myocardial infarction in young people. Cardiol J 2009; 16: 307-11.
 
3.
Al-Murayeh MA, Al-Masswary AA, Dardir MD, et al. Clinical presentation and short-term outcome of acute coronary syndrome in native young Saudi population. J Saudi Heart Assoc 2012; 24: 169-75.
 
4.
Incalcaterra E, Hoffmann E, Averna MR, Caimi G. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol 2004; 52: 287-312.
 
5.
Poledne R, Lorenzová A, Stávek P, et al. Proinflammatory status, genetics and atherosclerosis. Physiol Res 2009; 58 Suppl 2: S111-8.
 
6.
Bugert P, Vosberg M, Entelmann M, et al. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin Chem Lab Med 2004; 42: 997-1004.
 
7.
Volcik KA, Ballantyne CM, Coresh J, et al. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2007; 195: 76-82.
 
8.
Bugert P, Hoffmann MM, Winkelmann BR, et al. The variable number of tandem repeat polymorphism in the P-selectin glycoprotein ligand-1 gene is not associated with coronary heart disease. J Mol Med 2003; 81: 495-501.
 
9.
Ozben B, Diz-Kucukkaya R, Bilge AK, et al. The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. J Thromb Thrombolysis 2007; 23: 181-7.
 
10.
Thygesen K, Alpert JS, Jaffe AS, et al. ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Eur Heart J 2012; 33: 2551-67.
 
11.
Ghazouani L, Abboud N, Khalifa SBH, et al. Contribution of SELP and PSGL-1 genotypes and haplotypes to the presence of coronary heart disease in Tunisians. Mol Biol Rep 2011; 38: 495-501.
 
12.
Molenaar TJ, Twisk J, de Haas SA, et al. P-selectin as a candidate target in atherosclerosis. Biochem Pharmacol 2003; 66: 859-66.
 
13.
Hancer VS, Diz-Kucukkaya R, Nalcaci M. Turkish population data on the factor XIII Val34Leu, glycoprotein (GP)Ib Kozak and P-selectin glycoprotein ligand 1 (PSGL-1) loci. Cell Biochem Funct 2005; 23: 55-8.
 
14.
Roldán V, González-Conejero R, Marín F, Pineda J, Vicente V, Corral J. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. Am Heart J 2004; 148: 602-5.
 
15.
Lozano ML, Gonzalez-Conejero R, Corral J, et al. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesionand with ischaemic cerebrovascular disease. Br J Haematol 2001; 115: 969-76.
 
ISSN:2451-0637
Journals System - logo
Scroll to top